ClavystBio
- Investor (buy-side or sell-side research)
ClavystBio is a life sciences investor and venture builder set up by Temasek to accelerate the commercialization of breakthrough ideas into global health impact. We invest in biotech, med tech, diagnostics and digital health companies with a focus to leverage on strengths of Singapore and Asia to create health impact for patients globally.